<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 19-May-2020 [12:11:18] {PM}-->
<schema targetNamespace="http://ascendispharma.com/20200331" elementFormDefault="qualified" xmlns:asnd="http://ascendispharma.com/20200331" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://ascendispharma.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndOtherComprehensiveIncomeLoss" id="CondensedConsolidatedInterimStatementsOfProfitOrLossAndOtherComprehensiveIncomeLoss">
<link:definition>1002 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income / (Loss)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfProfitOrLossAndOtherComprehensiveIncomeLossParenthetical" id="CondensedConsolidatedInterimStatementsOfProfitOrLossAndOtherComprehensiveIncomeLossParenthetical">
<link:definition>1003 - Statement - Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income / (Loss) (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfFinancialPosition" id="CondensedConsolidatedInterimStatementsOfFinancialPosition">
<link:definition>1004 - Statement - Condensed Consolidated Interim Statements of Financial Position</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimStatementsOfChangesInEquity" id="CondensedConsolidatedInterimStatementsOfChangesInEquity">
<link:definition>1005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CondensedConsolidatedInterimCashFlowStatements" id="CondensedConsolidatedInterimCashFlowStatements">
<link:definition>1006 - Statement - Condensed Consolidated Interim Cash Flow Statements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/GeneralInformation" id="GeneralInformation">
<link:definition>1007 - Disclosure - General Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertainty" id="CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertainty">
<link:definition>1009 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SignificantEventsInTheReportingPeriod" id="SignificantEventsInTheReportingPeriod">
<link:definition>1010 - Disclosure - Significant Events In The Reporting Period</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/Revenue" id="Revenue">
<link:definition>1011 - Disclosure - Revenue</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformation" id="SegmentInformation">
<link:definition>1012 - Disclosure - Segment Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPayment" id="WarrantsAndShareBasedPayment">
<link:definition>1013 - Disclosure - Warrants and Share-based Payment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapital" id="ShareCapital">
<link:definition>1014 - Disclosure - Share Capital</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1015 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1016 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueTables" id="RevenueTables">
<link:definition>1017 - Disclosure - Revenue (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentTables" id="WarrantsAndShareBasedPaymentTables">
<link:definition>1018 - Disclosure - Warrants and Share-based Payment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformationDetail" id="CriticalAccountingJudgmentsAndKeySourcesOfEstimationUncertaintyAdditionalInformationDetail">
<link:definition>1019 - Disclosure - Critical Accounting Judgments and Key Sources of Estimation Uncertainty - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail" id="RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossDetail">
<link:definition>1020 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail" id="RevenueScheduleOfRevenueRecognizedInStatementsOfProfitOrLossParentheticalDetail">
<link:definition>1021 - Disclosure - Revenue - Schedule of Revenue Recognized in Statements of Profit or Loss (Parenthetical) (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/SegmentInformationAdditionalInformationDetail" id="SegmentInformationAdditionalInformationDetail">
<link:definition>1022 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentWarrantActivityAdditionalInformationDetail" id="WarrantsAndShareBasedPaymentWarrantActivityAdditionalInformationDetail">
<link:definition>1023 - Disclosure - Warrants and Share-based Payment - Warrant Activity - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail" id="WarrantsAndShareBasedPaymentScheduleOfWarrantActivityDetail">
<link:definition>1024 - Disclosure - Warrants and Share-based Payment - Schedule of Warrant Activity (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/WarrantsAndShareBasedPaymentSummaryOfWarrantCompensationCostDetail" id="WarrantsAndShareBasedPaymentSummaryOfWarrantCompensationCostDetail">
<link:definition>1025 - Disclosure - Warrants and Share-based Payment - Summary of Warrant Compensation Cost (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ascendispharma.com/role/ShareCapitalAdditionalInformationDetail" id="ShareCapitalAdditionalInformationDetail">
<link:definition>1026 - Disclosure - Share Capital - Additional Information (Detail)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20200331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20200331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20200331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="asnd-20200331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
<import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd" />
<import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
<element name="StatementTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="Warrant1Member" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_Warrant1Member" substitutionGroup="xbrli:item" />
<element name="StatementLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementLineItems" substitutionGroup="xbrli:item" />
<element name="NonCurrentAssetsFinanceLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_NonCurrentAssetsFinanceLiabilitiesAbstract" substitutionGroup="xbrli:item" />
<element name="ReceivableFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_ReceivableFromAssociate" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DistributableEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_DistributableEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CostsOfCapitalIncreaseDecrease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_CostsOfCapitalIncreaseDecrease" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NoncashConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NoncashConsideration" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ChangesInWorkingCapitalAbstract" substitutionGroup="xbrli:item" />
<element name="AdjustmentsForIncreaseDecreaseInPrepayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_AdjustmentsForIncreaseDecreaseInPrepayments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CashDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_CashDeposits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ShortTermMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_ShortTermMarketableSecurities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_TextBlockAbstract" substitutionGroup="xbrli:item" />
<element name="SignificantEventsInTheReportingPeriodTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_SignificantEventsInTheReportingPeriodTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfNewAndAmendedStandardsAdoptionPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfRevenueRecognizedInTheStatementOfProfitOrLossExplanatory" substitutionGroup="xbrli:item" />
<element name="DisclosureOfWarrantCompensationsCostExplanatory" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfWarrantCompensationsCostExplanatory" substitutionGroup="xbrli:item" />
<element name="RevenueFromSaleOfClinicalSupply" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_RevenueFromSaleOfClinicalSupply" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DeferredRevenueFromAssociate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_DeferredRevenueFromAssociate" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfReportableOperatingSegments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="asnd_NumberOfReportableOperatingSegments" substitutionGroup="xbrli:item" />
<element name="AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_AggregateNumberOfOtherEquityInstrumentsCancelledInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfInstrumentsAuthorisedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="DisclosureOfEmployeeCompensationCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfEmployeeCompensationCostsAbstract" substitutionGroup="xbrli:item" />
<element name="DisclosureOfWarrantActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_DisclosureOfWarrantActivityLineItems" substitutionGroup="xbrli:item" />
<element name="NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_NumberOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="asnd_WeightedAverageExercisePriceOfOtherEquityInstrumentsVestedInSharebasedPaymentArrangement" substitutionGroup="xbrli:item" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="StatementOfComprehensiveIncomeProfitOrLossLocationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_StatementOfComprehensiveIncomeProfitOrLossLocationMember" substitutionGroup="xbrli:item" />
<element name="GeneralAndAdministrativeExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_GeneralAndAdministrativeExpenseMember" substitutionGroup="xbrli:item" />
<element name="ResearchAndDevelopmentCostMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="asnd_ResearchAndDevelopmentCostMember" substitutionGroup="xbrli:item" />
</schema>
